MedPage Today) -- Aducanumab (Aduhelm) infusions combined with focused ultrasound led to lower cerebral amyloid-beta levels in Alzheimer's disease, a proof-of-concept trial showed. The investigational treatment involved creating an opening in...
.png)
Copyright © 2023 googlenewsandentertainment. All Rights Reserved
